Staar Surgical (STAA) Receivables (2010 - 2026)

Staar Surgical has reported Receivables for 17 years, with the latest figure at $81.2 million in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 103.19% year-over-year to $81.2 million; the trailing twelve-month figure through Apr 2026 stood at $81.2 million (up 103.19% YoY), and the FY2026 full-year result was $50.4 million, down 52.23% from the prior year.
• Receivables for Q2 2026 stood at $81.2 million, up from $50.4 million in the prior quarter.
• The five-year high for Receivables was $112.4 million in Q3 2023, with the low at $34.4 million in Q2 2025.
• Historically, Receivables has averaged $72.2 million across 5 years, with a median of $63.5 million in 2023.
• Annual changes were most pronounced in 2025 — Receivables sank 63.28% — and 2026, when it jumped 103.19%.
• Staar Surgical's Receivables stood at $62.5 million in 2022, then jumped by 51.9% to $94.9 million in 2023, then rose by 11.1% to $105.4 million in 2024, then tumbled by 42.99% to $60.1 million in 2025, then surged by 35.05% to $81.2 million in 2026.
• The last three Receivables figures came in at $81.2 million (Q2 2026), $50.4 million (Q1 2026), and $60.1 million (Q3 2025), per Business Quant data.